[New perspectives in non-invasive treatment of sinusitis].
A randomized multicenter study of sinuforte efficacy and safety was made in 120 patients with sinusitis. All the patients were randomized into two groups: the study group of 60 patients received monotherapy with sinuforte in a single daily dose for 7 days; the control group of 60 patients received conventional treatment for 7 days. The efficacy of the treatments was assessed by the results of clinical, endoscopic and laboratory tests. The analysis of the study results shows that sinuforte monotherapy is an effective and safe in the treatment of exudative sinusitis of mild and moderate severity.
Kriukov
A I
AI
Kunel'skaia
N L
NL
Turovskiĭ
A B
AB
Artem'ev
M E
ME
Ibragimova
Z S
ZS
D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D031824:Cyclamen; D004305:Dose-Response Relationship, Drug; D004724:Endoscopy; D005122:Exudates and Transudates; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009093:Mucus / Q000187:drug effects / Q000378:metabolism; D009297:Nasal Mucosa / Q000187:drug effects / Q000378:metabolism; D028321:Plant Preparations / Q000008:administration & dosage*; D012720:Severity of Illness Index; D012852:Sinusitis / Q000175:diagnosis / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome